
- 1D
- 1W
- 1M
- 1Y
- 5Y
- YTD
About Codex DNA
Codex DNA, Inc. operates as a biotech company. The Company engages in development of automation solutions for DNA, RNA, and protein synthesis to enable customers to program and synthetic biology that creates sustainable healthcare and technology solutions. Codex DNA serves customers in the United States.
News
Stock Analysis

last close
$2.21
1-mo return
19.5%
3-mo return
-35.9%
avg daily vol.
340.94T
52-week high
14.99
52-week low
1.67
market cap.
$65M
forward pe
-
annual div.
-
roe
-197%
ltg forecast
-
dividend yield
-
annual rev.
$14M
inst own.
57.4%